SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MaaT Pharma Reports Financial Results for the Third Quarter 2026

Regulatory News:MaaT Pharma (EURONEXT:MAAT — the “Company”), a late-stage clinical biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today reported its cash position and…

MAAT

Related stories